Remdesivir for the Treatment of COVID-19
- PMID: 35166509
Remdesivir for the Treatment of COVID-19
Similar articles
-
Remdesivir: a pendulum in a pandemic.BMJ. 2020 Nov 24;371:m4560. doi: 10.1136/bmj.m4560. BMJ. 2020. PMID: 33234523 No abstract available.
-
Remdesivir for patients with COVID-19.CMAJ. 2021 Jan 25;193(4):E125. doi: 10.1503/cmaj.202505. Epub 2021 Jan 6. CMAJ. 2021. PMID: 33408097 Free PMC article. No abstract available.
-
Assessing the evidence on remdesivir.Lancet Infect Dis. 2021 Dec;21(12):1630-1631. doi: 10.1016/S1473-3099(21)00695-2. Lancet Infect Dis. 2021. PMID: 34838222 Free PMC article. No abstract available.
-
Remdesivir as a broad-spectrum antiviral drug against COVID-19.Eur Rev Med Pharmacol Sci. 2021 Jan;25(1):541-548. doi: 10.26355/eurrev_202101_24426. Eur Rev Med Pharmacol Sci. 2021. PMID: 33506946 Review.
-
Safety profile of the antiviral drug remdesivir: An update.Biomed Pharmacother. 2020 Oct;130:110532. doi: 10.1016/j.biopha.2020.110532. Epub 2020 Jul 22. Biomed Pharmacother. 2020. PMID: 32707440 Free PMC article. Review. No abstract available.
Cited by
-
Clinical Characteristics and Mortality-Associated Factors in COVID-19 Critical Patients in a Portuguese ICU.Cureus. 2022 Sep 26;14(9):e29610. doi: 10.7759/cureus.29610. eCollection 2022 Sep. Cureus. 2022. PMID: 36320987 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources